Danaher Corp
DHRNYSEIndustrial Instruments For Measurement, Display, and ControlFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 26, 2026Last filing: 10-Q on Jul 21, 2026Score 12/3025% above fair value
$227.97−4.26 (-1.83%)
Close on Nov 2, 2026Market cap $160.26BP/E 40.5Yield –
Danaher Biotechnology by Year
Biotechnology — Intangibles Amortization % of Segment Sales (MD&A) (%)
Danaher Biotechnology: 12.4% in FY2025, down 0.4 pts from a year earlier.
Latest, FY2025
12.4%
Period ended Dec 31, 2025
Change on a year earlier
-0.4 pts
12.8% in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below
Where the FY2025 figure comes from
Source: Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗
Reported for Q1, Q2, Q3 (10-Q) and full year (10-K), with no standalone Q4 reported.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Biotechnology — Intangibles Amortization % of Segment Sales (MD&A) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12.4% | -0.4 pts | Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 12.8% | +0.8 pts | Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗ |
| FY2023 | Dec 31, 2023 | 12.0% | +2.7 pts | Danaher SEC 10-K (FY2025, filed 2026-02-24) ↗ |
| FY2022 | Dec 31, 2022 | 9.3% | – | Danaher SEC 10-K (FY2024, filed 2025-02-20) ↗ |
Cite this data
StockData. (2026). Danaher Biotechnology (%), annual FY2022–FY2025 [Data set]. Compiled from Danaher SEC filings and investor materials. https://stockdatahq.com/stocks/dhr/kpis/mda-amort-pct-sales-biotech
See every metric in the Danaher KPI table. Data updated Nov 2, 2026.